Overview
Superior mesenteric artery (SMA) embolism is a life-threatening condition characterized by obstruction of blood flow to the intestines, often leading to bowel ischemia and necrosis if not promptly treated 1234.Diagnosis
Clinical Presentation: Abdominal pain, nausea, vomiting, and signs of systemic inflammatory response 12.
Imaging: CT angiography and mesenteric Doppler ultrasound to identify the embolus and assess bowel perfusion 12.
Laboratory Tests: Elevated lactate levels, leukocytosis, and coagulation profile abnormalities 12.
Peritoneal Signs: Absence of peritoneal signs initially helps in selecting patients for endovascular treatment 23.Management
First-Line Treatments:
- Percutaneous Mechanical Thrombectomy: Effective for early acute SMA embolism, using devices like the AngioJet catheter 2.
- Local Thrombolysis: Intraarterial urokinase infusion for patients without signs of bowel infarction 34.
Adjunctive Treatments:
- Stenting: Considered in cases where recanalization is achieved but patency needs to be maintained 1.
- Surgical Intervention: Reserved for cases with failed endovascular treatment, bowel necrosis, or complications like septic shock 23.Special Populations
Elderly: Endovascular approaches like transbrachial and transfemoral methods show promise but require careful patient selection due to anatomical variations 1.
Comorbidities: Patients with multiple underlying diseases may have higher complication risks, necessitating individualized treatment plans 2.Key Recommendations
Consider Transbrachial Approach for Certain Patients: May offer advantages in terms of efficiency and recovery compared to transfemoral approach, particularly in specific anatomical scenarios (Evidence: Moderate) 1.
Early Percutaneous Mechanical Thrombectomy: Effective for early acute SMA embolism, aiming for complete embolus removal to prevent bowel infarction (Evidence: Moderate) 2.
Intraarterial Urokinase for Selected Patients: Can be an effective alternative to surgery in patients without clinical signs of intestinal infarction, though close monitoring is essential (Evidence: Weak) 34.References
1 Guo W, Chen L, Li X, Zhu L, Zhang H, Wu B et al.. A comparative study on the transbrachial and transfemoral approaches for the treatment of superior mesenteric artery lesions. The journal of vascular access 2025. link
2 Yu Z, Wang S, Lang D, Yin X, Lin Z, Hu S et al.. Percutaneous mechanical thrombectomy in the management of early acute superior mesenteric artery embolism. Vascular 2023. link
3 Wang G, Lu W, Xia Q, Mao B, Wang L, Li T et al.. Superior mesenteric arterial embolism: a retrospective study of local thrombolytic treatment with urokinase in West China. International journal of clinical practice 2003. link
4 Simó G, Echenagusia AJ, Camúñez F, Turégano F, Cabrera A, Urbano J. Superior mesenteric arterial embolism: local fibrinolytic treatment with urokinase. Radiology 1997. link